Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staloral versus placebo for asthma control in grass-pollen allergic rhinitis
2014-003204-70Phase 4Active
- Sponsor
- Dr. Javier DomÃnguez Ortega
- Start
- Mar 2015
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of dermatophagoides pteronyssinus extract in allergic rhinitis (AR) and asthma (2 arms), sponsored by Dr. Javier DomÃnguez Ortega. Primary endpoint: Composite Asthma Severity Index (CASI). Started Mar 2015; status: active.
02
Drugs
dermatophagoides pteronyssinus extract
03
Conditions
allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on 2014-003204-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003204-70.